When Public Health Becomes Profit over Patients
Public health programs like 340B are designed with a clear and urgent purpose: to improve community health, expand access to care, and protect the most vulnerable among us. Whether it’s ensuring access to lifesaving medications, funding prevention initiatives, or supporting safety-net providers, these programs exist because the private market alone has historically failed to meet the needs of all patients equitably.
Yet increasingly, we are seeing a disturbing shift—public health programs are being leveraged, reshaped, and in some cases outright commandeered to serve as revenue streams for for-profit entities. This public health piracy threatens not only the integrity of these programs, but also the patients they were built to serve.
The Original Intent: Patients First
Programs like 340B, Medicaid, Medicare, and drug pricing initiatives were created to close gaps in care, not to create new profit centers. Their structure reflects a social contract: public dollars are invested to achieve public good. That includes expanding access, reducing disparities, and improving outcomes for communities that have long been underserved.
When these programs are used as vehicles for profit maximization, their core mission becomes diluted. Dollars that should be directed toward patient care, support services, and community health infrastructure are instead diverted into complex financial arrangements, administrative overhead, or shareholder returns.
The Rise of Revenue Optimization Strategies
In recent years, strategies by for-profit entities have emerged that allow them to extract value from public programs in ways that were never intended.
These include:
Exploiting reimbursement structures to maximize margins rather than improve care delivery
Using intermediaries and contract arrangements that obscure where funds are actually going
Shifting focus from patient benefit to financial performance metrics.
Leveraging regulatory gaps to operate in gray areas without clear accountability
While these strategies may be legal, they raise serious ethical and policy concerns. Legality should not be confused with legitimacy—particularly when public health is at stake.
Evidence from Minnesota’s 340B Reporting Initiative
Minnesota’s 340B Covered Entity Report, established to bring transparency to the program, provides critical insight into how 340B revenues are actually distributed. The findings raise serious concerns:
Significant diversion of funds to middlemen: Payments to contract pharmacies and third-party administrators exceeded $120 million, representing roughly 16–20% of gross 340B revenues.
Negative financial outcomes for true safety-net providers: Approximately 10% of federal grantees reported negative net 340B revenue after paying fees to contract pharmacies and vendors.
Less than 2% of 340B net revenues were allocated to federal grantee entities
Disproportionate gains for large hospital systems: Minnesota providers generated at least $630 million in 340B revenue, with the largest hospital systems capturing the majority of those profits.
These findings illustrate a troubling reality: the 340B program, like many public programs is increasingly functioning as a revenue-generating mechanism for large health systems and corporate intermediaries, rather than a targeted support system for vulnerable patients.
The Impact on Patients and Communities
When public health programs are treated as revenue generators, patients often bear the consequences:
Reduced access to affordable medications or services, despite programs designed to lower costs
Fragmented care delivery, as financial incentives drive decision-making
Erosion of trust in health systems and public institutions
Widening health disparities, particularly for marginalized populations
At its worst, this dynamic creates a system where the appearance of support exists, but the substance fails the test.
The Accountability Gap
One of the biggest challenges is the lack of transparency and accountability in how funds from public programs are used. Without clear reporting requirements or enforceable standards tied to patient benefit, it becomes difficult to ensure that these programs are fulfilling their intended purpose.
Public dollars should come with public accountability. That means:
Defining and measuring “patient benefit” in concrete terms
Requiring transparent reporting on how funds are used
Ensuring oversight mechanisms that prioritize patient outcomes over financial returns
Aligning incentives so that doing well financially requires doing right by patients
Reclaiming the Purpose of Public Health Programs
The solution is not to eliminate partnerships with private entities—these collaborations can be valuable when structured appropriately. But the terms of engagement must be clear: public programs should never be repurposed primarily as revenue engines.
Instead, policymakers, advocates, and stakeholders must work together to:
Recenter programs on patient outcomes and community impact
Close loopholes that enable exploitation
Strengthen guardrails to ensure funds are used as intended
Elevate patient voices in decision-making processes
At a time when public health challenges are growing more complex—from chronic disease to emerging infectious threats—we cannot afford to let mission drift undermine our most important tools.
Public health programs are not commodities. They are commitments—to equity, to access, and to the fundamental belief that health is a public good. Protecting that vision requires vigilance, transparency, and a willingness to confront uncomfortable truths about how these programs are being misused today. Because when public health becomes a profit strategy, it is patients who ultimately pay the price.
